News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Nico Gagelmann Shares Article on How Remission Conversion Drives Outcomes After CAR T-cell Therapy for Multiple Myeloma
Nico Gagelmann
Jun 14, 2025, 18:04

Nico Gagelmann Shares Article on How Remission Conversion Drives Outcomes After CAR T-cell Therapy for Multiple Myeloma

Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) and Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared a post on X:

“Finally out
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma
Now in Blood Journals Portfolio
Timely for EHA2025″

Title: Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST

Authors: Maximilian Merz, Nico Gagelmann, Samih Smaili, Sarah Flossdorf, Sandra Sauer, Christof Scheid, Bastian von Tresckow, Gerald Georg Wulf, Katja C Weisel, Igor Blau, Monika Engelhardt, Ralph Wäsch, Natalie Schub, Raphael Teipel, Judith S. Hecker, Johannes M. Waldschmidt, Britta Besemer, Ben-Niklas Baermann, Simon Call, Leo Hansmann, Francis Ayuketang Ayuk, Marc S. Raab, Hermann Einsele, Uwe Platzbecker, Nicolaus Kröger

You can read the Full Article on Blood Journals Portfolio

Nico Gagelmann Shares Article on How Remission Conversion Drives Outcomes After CAR T-cell Therapy for Multiple Myeloma

More posts featuring Nico Gagelmann.

Bastian von Tresckow Ben-Niklas Baermann Britta Besemer cancer CAR T-cell therapy Christof Scheid Francis Ayuketang Ayuk Gerald Georg Wulf Hermann Einsele Igor Blau Johannes M Waldschmidt Judith S. Hecker Katja C. Weisel Leo Hansmann Marc S. Raab Maximilian Merz Monika Engelhardt multiple myeloma Natalie Schub Nico Gagelmann Nicolaus Kröger OncoDaily Oncology Ralph Wäsch Raphael Teipel Remission Conversion Samih Smaili Sandra Sauer Sarah Flossdorf Simon Call Uwe Platzbecker
Special Coverage
Blog
Jul 17, 2025, 14:38
UF Health Cancer Center Leads Innovation at 17th AACI CRI Meeting
Oncolibrary
Jul 17, 2025, 14:21
CUE-101 and Pembrolizumab Show Promising Results in HPV-Positive Head and Neck Cancer
Oncolibrary
Jul 17, 2025, 13:13
MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress
Blog
Jul 17, 2025, 12:42
Late-Breaking Abstract Submission for the SIOP Congress Is Now Open
Blog
Jul 17, 2025, 12:35
Sophia Victoria Lozano Ballena: Honored to Participate in the ESO's Masterclass in Clinical Oncology
Blog
Jul 17, 2025, 12:24
ENYGO Heads to Tbilisi for Cutting-Edge Oncology Training - ESGO
Blog
Jul 17, 2025, 12:15
From Data to Vaccination, from Screening to Accessibility - European Cancer Organisation
Blog
Jul 17, 2025, 12:05
Honoring Steve Mathews’ 27-Year-Long Remarkable Journey - NFCR
Career
Jul 17, 2025, 11:57
Asfand Yar Cheema: A Doctor’s Journey From Pakistan To The USA
Blog
Jul 17, 2025, 11:52
Jennifer Bires: Real Talk. Real Support. Real Experts - Sept 13 Women’s Cancer Education Forum in DC
Blog
Jul 17, 2025, 11:50
UICC Members Transforming Cancer Care: Highlights on Mexico, Arab Countries and Australia
Blog
Jul 17, 2025, 11:43
Aakash Desai: SC vs. IV in Immunotherapy - Are We Gaining Time but Losing Equity?